Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation.

Fukushima S, Yoshida A, Honda K, Maeshima AM, Narita Y, Yamada T, Shibui S, Tsuda H.

Brain Tumor Pathol. 2014 Jan;31(1):11-6. doi: 10.1007/s10014-013-0139-z. Epub 2013 Mar 17.

PMID:
23504125
2.

Correlation of chromosomes 1p and 19q status and expressions of O6-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study.

Huang L, Jiang T, Yuan F, Li GL, Cui Y, Liu EZ, Wang ZC.

Neuropathol Appl Neurobiol. 2009 Aug;35(4):367-79. doi: 10.1111/j.1365-2990.2008.01002.x. Epub 2008 Nov 18.

PMID:
19019173
4.

Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.

Barresi V, Buttarelli FR, Vitarelli EE, Arcella A, Antonelli M, Giangaspero F.

Hum Pathol. 2009 Dec;40(12):1738-46. doi: 10.1016/j.humpath.2009.04.026. Epub 2009 Aug 27.

PMID:
19716156
5.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.

Acta Neuropathol. 2009 Oct;118(4):469-74. doi: 10.1007/s00401-009-0561-9. Epub 2009 Jun 25.

PMID:
19554337
6.

Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.

Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G.

J Neuropathol Exp Neurol. 1996 Jul;55(7):822-31.

PMID:
8965097
7.

Clonal analysis of gliomas.

Kattar MM, Kupsky WJ, Shimoyama RK, Vo TD, Olson MW, Bargar GR, Sarkar FH.

Hum Pathol. 1997 Oct;28(10):1166-79.

PMID:
9343324
8.

Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.

Decaestecker C, Lopes BS, Gordower L, Camby I, Cras P, Martin JJ, Kiss R, VandenBerg SR, Salmon I.

J Neuropathol Exp Neurol. 1997 Apr;56(4):391-402.

PMID:
9100670
9.

Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.

Debinski W, Slagle B, Gibo DM, Powers SK, Gillespie GY.

J Neurooncol. 2000 Jun;48(2):103-11.

PMID:
11083073
10.

[Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].

Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.

Zhonghua Zhong Liu Za Zhi. 2011 Oct;33(10):752-8. Chinese.

PMID:
22335907
11.

Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.

Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M.

Clin Cancer Res. 2005 Jan 1;11(1):267-72.

12.

Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas.

Strik HM, Deininger MH, Frank B, Schluesener HJ, Meyermann R.

J Neurooncol. 2001 May;53(1):13-20.

PMID:
11678425
13.

Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.

Zagzag D, Blanco C, Friedlander DR, Miller DC, Newcomb EW.

Hum Pathol. 2003 Jan;34(1):48-53.

PMID:
12605366
14.

Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.

Cassoni P, Senetta R, Castellano I, Ortolan E, Bosco M, Magnani I, Ducati A.

Am J Surg Pathol. 2007 May;31(5):760-9.

PMID:
17460461
15.

[Histological classification of human gliomas: state of art and controversies].

Figarella-Branger D, Bouvier C.

Bull Cancer. 2005 Apr;92(4):301-9. French.

16.

The significance of the expression of tumor suppressor gene DCC in human gliomas.

Nakatani K, Yoshimi N, Mori H, Sakai H, Shinoda J, Andoh T, Sakai N.

J Neurooncol. 1998 Dec;40(3):237-42.

PMID:
10066096
17.

Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines.

Sasaki A, Ishiuchi S, Kanda T, Hasegawa M, Nakazato Y.

Brain Tumor Pathol. 2001;18(1):13-21.

PMID:
11517969
18.

Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas.

Neder L, Marie SK, Carlotti CG Jr, Gabbai AA, Rosemberg S, Malheiros SM, Siqueira RP, Oba-Shinjo SM, Uno M, Aguiar PH, Miura F, Chammas R, Colli BO, Silva WA Jr, Zago MA.

Brain Pathol. 2004 Oct;14(4):399-405.

PMID:
15605987
19.
20.

Expression of transforming growth factor alpha in human gliomas.

Schlegel U, Moots PL, Rosenblum MK, Thaler HT, Furneaux HM.

Oncogene. 1990 Dec;5(12):1839-42.

PMID:
2284103

Supplemental Content

Support Center